Assessing Combined SBRT in Breast Cancer Non-Responders to Neoadjuvant Chemotherapy

NCT06596018 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

96

Enrollment

OTHER

Sponsor class

Conditions

Breast Adenocarcinoma

Interventions

RADIATION: SBRT
DRUG: Chemotherapy

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University